Clinical heterogeneity and immunotherapy outcomes in anti-GAD65 antibody-associated autoimmune encephalitis: a retrospective study
Therapeutic Advances in Neurological Disorders
Published online on June 10, 2026
Abstract
Therapeutic Advances in Neurological Disorders, Volume 19, January-December 2026.
Anti-glutamic acid decarboxylase 65 (GAD65) antibody-associated autoimmune encephalitis (AE) is characterized by diverse neurological manifestations and systemic autoimmune comorbidities, posing diagnostic and therapeutic challenges. This study aimed to ...
Anti-glutamic acid decarboxylase 65 (GAD65) antibody-associated autoimmune encephalitis (AE) is characterized by diverse neurological manifestations and systemic autoimmune comorbidities, posing diagnostic and therapeutic challenges. This study aimed to ...